🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06587178
Starting soon Not applicable

Semi-elemental Versus Polymeric EEN in the Preoperative Optimization for Patients with CD

NCT06587178 · tracked via the Priya Life Science China tracker
Sponsor
Wei Zhou
Phase
Not applicable
Started
2024-10-01
Last updated
2024-09-19

Condition(s) studied

Crohn DiseaseNutrition DisordersSurgery

Investigational drug(s) / intervention(s)

peptison liquidEnteral nutritional suspension

peptison liquid: CD patients requiring bowel resection and preoperative EEN were randomized to receive peptison liquid for 6 weeks.

Enteral nutritional suspension: CD patients requiring bowel resection and preoperative EEN were randomized to receive enteral nutritional suspension for 6 weeks.

Study summary

Growing evidence has shown that exclusive enteral nutrition (EEN) plays an important role in the preoperative optimization for patients with Crohn's disease (CD). However, the efficacy and safety of different types of enteral feeds including semi-elemental and polymeric enteral nutrition on CD have not been investigated. The aim of this study was to compare the role of semi-elemental and polymeric enteral nutrition on CD.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: 1. elective bowel resection for Crohn's disease; 2. preoperative diagnosis of Crohn's disease; 3. age between 18 to 65 years old; 4. malnutrition; 5. the Crohn's disease activity index over 150; 6. nasal feeding. Exclusion Criteria: 1. emergency surgery; 2. preoperative exclusive enteral nutrition before three months; 3. can not tolerate enteral nutrition; 4. less than 6 weeks of exclusive enteral nutrition; 5. preoperative corticosteroids within 3 months; 6. history of gastrointestinal surgery; 7. isolated colon disease; 8. metabolic disease (diabetes, hyperthyroidism).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Wei Zhou Hangzhou Zhejiang

More Wei Zhou trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06587178 on ClinicalTrials.gov ↗ ← All trials in China